Comparison of Oral P2Y12 Inhibitors in Acute Coronary Syndrome

被引：0
|
作者：
Ferracane, Elisa [1 ]
Bartoli, Laura [1 ]
Trippoli, Sabrina [1 ]
Messori, Andrea [1 ]
机构：
[1] Reg Toscana, Via Alderotti 46-N, I-50139 Florence, Italy
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2020年 / 135卷
关键词：
D O I：
10.1016/j.amjcard.2020.08.023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [21] Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
    Tantry, Udaya S.
    Navarese, Eliano P.
    Myat, Aung
    Gurbel, Paul A.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 460 - 470
  • [22] Efficacy and Safety of Oral P2Y12 Inhibitors in Older Patients with Acute Coronary Syndrome: A Frequentist Network Meta-Analysis
    Izza Shahid
    Muhammad Abdullah Nizam
    Vanita Motiani
    Ritesh G. Menezes
    Unaiza Naeem
    Tariq Jamal Siddiqi
    Tehlil Rizwan
    Fahd Makhdom
    Pradhum Ram
    Muhammad Shariq Usman
    Drugs & Aging, 2021, 38 : 1003 - 1016
  • [23] Efficacy and Safety of Oral P2Y12 Inhibitors in Older Patients with Acute Coronary Syndrome: A Frequentist Network Meta-Analysis
    Shahid, Izza
    Nizam, Muhammad Abdullah
    Motiani, Vanita
    Menezes, Ritesh G.
    Naeem, Unaiza
    Siddiqi, Tariq Jamal
    Rizwan, Tehlil
    Makhdom, Fahd
    Ram, Pradhum
    Usman, Muhammad Shariq
    DRUGS & AGING, 2021, 38 (11) : 1003 - 1016
  • [24] Comparison of the efficacy and safety between different oral P2Y12 receptor inhibitors in patients with acute coronary syndrome: a systematic review and meta-analysis
    Lepone, A.
    Castiglione, V.
    Gentile, F.
    Scalera, S.
    Negro, F.
    Ridolfi, L.
    Favilli, M.
    Italiano, A.
    Mazzola, M.
    Masaracchia, G.
    Mancini, S.
    Guarini, G.
    Masini, G.
    De Caterina, R.
    Morrone, D.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1231 - 1231
  • [25] Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy
    Lugo Gavidia, L.
    Vivas, D.
    De La Hera, J. M.
    Tello-Montoliu, A.
    Marcano, A. L.
    Besteiro, A.
    Silva, I.
    Gomez-Polo, J. C.
    Playan, J.
    Gomez-Hospital, J. A.
    Cequier, A.
    Marin, F.
    Roldan, I.
    Ferreiro, J. L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 73 - 73
  • [26] Is Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Clinically Justified? Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Is Clinically Justified Response
    Collet, Jean-Philippe
    Silvain, Johanne
    Bellemain-Appaix, Anne
    Montalescot, Gilles
    CIRCULATION, 2014, 130 (21) : 1903 - 1903
  • [27] P2Y12 Inhibitor Adherence Patterns in Patients with Acute Coronary Syndrome
    Ozaki, Aya
    Ko, Dennis T.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Sud, Maneesh
    Jackevicius, Cynthia A.
    CIRCULATION, 2021, 144
  • [28] P2Y12 inhibitor in acute coronary syndromes
    Wiwanitkit, Viroj
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 249 - 249
  • [29] Is Pretreatment With P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome Clinically Justified? Pretreatment with P2Y12 Inhibitors in Non-ST-Segment-Elevation Acute Coronary Syndrome: An Outdated and Harmful Strategy
    Collet, Jean-Philippe
    Silvain, Johanne
    Bellemain-Appaix, Anne
    Montalescot, Gilles
    CIRCULATION, 2014, 130 (21) : 1904 - 1914
  • [30] Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome
    Kim, Kibum
    Touchette, Daniel R.
    Cavallari, Larisa H.
    Ardati, Amer K.
    DiDomenico, Robert J.
    CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (05) : 533 - 546
12345